Published in Mol Biol Cell on September 13, 2006
PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol (2009) 4.83
Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology (2009) 2.13
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med (2011) 1.52
RalA functions as an indispensable signal mediator for the nutrient-sensing system. J Biol Chem (2008) 1.28
PTEN at a glance. J Cell Sci (2012) 1.26
Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress. J Biol Chem (2010) 1.05
Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer (2012) 1.00
Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ (2012) 0.92
Protein interactions of phosphatase and tensin homologue (PTEN) and its cancer-associated G20E mutant compared by using stable isotope labeling by amino acids in cell culture-based parallel affinity purification. J Biol Chem (2011) 0.90
Involvement of GLTSCR2 in the DNA Damage Response. Am J Pathol (2011) 0.90
PICT1 expression is a poor prognostic factor in non-small cell lung cancer. Oncoscience (2014) 0.88
PTEN modulators: a patent review. Expert Opin Ther Pat (2013) 0.88
ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells. Autophagy (2015) 0.87
Nucleolar localization of GLTSCR2/PICT-1 is mediated by multiple unique nucleolar localization sequences. PLoS One (2012) 0.84
GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein. J Virol (2009) 0.83
Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors. Drug Des Devel Ther (2014) 0.83
PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression. Br J Cancer (2013) 0.81
GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer. J Cell Mol Med (2015) 0.80
Nucleolar stress induces ubiquitination-independent proteasomal degradation of PICT1 protein. J Biol Chem (2014) 0.76
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev (2015) 0.76
A ribosomal tactic to halt cancer. Nat Med (2011) 0.76
PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway. Oncotarget (2016) 0.75
PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway. Oncotarget (2016) 0.75
The phosphoinositide 3-kinase pathway. Science (2002) 24.72
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A (1999) 11.38
Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47
The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A (1998) 6.98
RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A (2002) 6.84
The multiple roles of PTEN in tumor suppression. Cell (2000) 6.71
Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol (2000) 5.22
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90
Regulation of PTEN by Rho small GTPases. Nat Cell Biol (2005) 4.51
Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J (2000) 4.26
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol (2000) 3.61
Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst (1999) 3.41
Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem (2001) 3.27
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev (2005) 3.25
PTEN function: how normal cells control it and tumour cells lose it. Biochem J (2004) 3.06
Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci U S A (2003) 2.92
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A (2000) 2.65
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A (2001) 2.50
Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem (2000) 2.09
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet (1999) 2.08
Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev (2005) 1.99
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem (2003) 1.97
Direct identification of PTEN phosphorylation sites. FEBS Lett (2002) 1.80
PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol (2005) 1.67
Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem (2005) 1.60
Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell (2004) 1.57
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell (2002) 1.48
Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem (2004) 1.46
A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics (2000) 1.39
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin Cancer Res (2001) 1.11
Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+/-SHIP-/- mice: a novel model of myelodysplasia. Blood (2004) 1.01
Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines. Int J Cancer (2004) 0.91
Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res (2002) 0.88
Production of research-grade antibody by in vivo electroporation of DNA-encoding target protein. Anal Biochem (2005) 0.87
Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol (2002) 0.86
Analysis of PTEN/MMAC1 alteration in neuroblastoma. Cancer Genet Cytogenet (2001) 0.84
Oncogenic mutations of ALK kinase in neuroblastoma. Nature (2008) 5.80
Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. Genome Res (2003) 3.50
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol (2006) 3.19
Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat (2002) 2.92
Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science (2009) 2.23
Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol Chem (2007) 2.03
Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Chest (2011) 2.03
Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan. Pediatr Blood Cancer (2006) 1.99
Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol (2005) 1.99
Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. Cancer Cell (2005) 1.94
Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis. Sci Signal (2012) 1.86
Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J Biol Chem (2004) 1.80
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin Cancer Res (2010) 1.79
Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J Natl Cancer Inst (2002) 1.78
PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res (2003) 1.75
Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol (2002) 1.72
Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem (2004) 1.65
Local change in phospholipid composition at the cleavage furrow is essential for completion of cytokinesis. J Biol Chem (2005) 1.63
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. J Clin Oncol (2011) 1.62
HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J Biol Chem (2001) 1.60
CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res (2005) 1.57
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med (2011) 1.52
Biological role of anaplastic lymphoma kinase in neuroblastoma. Am J Pathol (2005) 1.51
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res (2003) 1.49
Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol (2009) 1.48
Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J Biol Chem (2003) 1.47
Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem (2004) 1.46
LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res (2005) 1.44
p73, a sophisticated p53 family member in the cancer world. Cancer Sci (2005) 1.39
The Human Anatomic Gene Expression Library (H-ANGEL), the H-Inv integrative display of human gene expression across disparate technologies and platforms. Nucleic Acids Res (2005) 1.39
Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol Cell Biol (2006) 1.36
Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med (2009) 1.36
Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med (2009) 1.36
Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes. J Clin Invest (2008) 1.33
KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem (2008) 1.31
NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J Biol Chem (2003) 1.30
The tyrosine kinase Fer is a downstream target of the PLD-PA pathway that regulates cell migration. Sci Signal (2009) 1.29
RalA functions as an indispensable signal mediator for the nutrient-sensing system. J Biol Chem (2008) 1.28
L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region. J Neurosci (2005) 1.26
Molecular and genetic bases of neuroblastoma. Int J Clin Oncol (2012) 1.25
Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem (2006) 1.25
Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem J (2004) 1.25
Gastric schwannoma: sonographic findings. J Ultrasound Med (2004) 1.23
Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun (2005) 1.22
Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I {alpha}. J Exp Med (2005) 1.22
Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol (2005) 1.21
A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity. Biochem Biophys Res Commun (2003) 1.19
Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem (2008) 1.19
Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology (2008) 1.19
Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J Biol Chem (2009) 1.19
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature. Clin Cancer Res (2010) 1.15
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma. Dis Model Mech (2012) 1.14
Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models. Biochimie (2010) 1.14
Crucial role of the small GTPase ARF6 in hepatic cord formation during liver development. Mol Cell Biol (2006) 1.12
Identification of novel candidate compounds targeting TrkB to induce apoptosis in neuroblastoma. Cancer Med (2014) 1.10
Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells. Oncogene (2005) 1.10
Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging (2008) 1.08
Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem (2002) 1.08
Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J Exp Med (2013) 1.08
UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Oncogene (2005) 1.08
Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim Biophys Acta (2005) 1.08
Intussusception induced by villous tumor of the colon: sonographic findings. J Clin Ultrasound (2002) 1.07
Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis (2007) 1.07
Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol (2013) 1.06
Phospholipase D2 functions as a downstream signaling molecule of MAP kinase pathway in L1-stimulated neurite outgrowth of cerebellar granule neurons. J Neurochem (2004) 1.06
Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J Clin Invest (2010) 1.06
Sonographic diagnosis and successful nonoperative management of sealed perforated duodenal ulcer. J Clin Ultrasound (2003) 1.06
Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis. EMBO J (2007) 1.05
A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method. J Ultrasound Med (2002) 1.05
S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem Biophys Res Commun (2007) 1.04
Phosphatidylinositol 4-phosphate 5-kinase is essential for ROCK-mediated neurite remodeling. J Biol Chem (2002) 1.04
Rat islet culture in serum-free medium containing silk protein sericin. J Hepatobiliary Pancreat Surg (2009) 1.03
Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis. Int J Cancer (2004) 1.03
Regulation of Bin1 SH3 domain binding by phosphoinositides. EMBO J (2004) 1.03
Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing. Biol Pharm Bull (2013) 1.03
Clinicopathological relevance of UbcH10 in breast cancer. Cancer Sci (2009) 1.02
p53: the attractive tumor suppressor in the cancer research field. J Biomed Biotechnol (2010) 1.02
Loss of PIP5KIbeta demonstrates that PIP5KI isoform-specific PIP2 synthesis is required for IP3 formation. Proc Natl Acad Sci U S A (2008) 1.02
ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis. Exp Lung Res (2007) 1.02
Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem Pharmacol (2011) 1.01
Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function. J Biol Chem (2002) 1.01
The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis. Biochem Biophys Res Commun (2006) 1.01
Phosphatidylinositol-4-phosphate 5-kinases and phosphatidylinositol 4,5-bisphosphate synthesis in the brain. J Biol Chem (2010) 1.01
Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1. PLoS One (2011) 1.01
Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem J (2005) 1.00
Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation. Biochim Biophys Acta (2003) 1.00
A new PICTure of nucleolar stress. Cancer Sci (2012) 0.98
Capturing the mammalian Hippo: elucidating its role in cancer. Cancer Sci (2013) 0.97
High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol (2009) 0.97
Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. J Biochem (2003) 0.97
Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation. J Biol Chem (2008) 0.97